ARQT - Arcutis Biotherapeutics Inc
24.59
-0.230 -0.935%
Share volume: 973,183
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$24.82
-0.23
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 11-06-2024 | 02-25-2025 | 05-06-2025 | 10-28-2025 | 02-25-2026 | |
| Total revenue | 49.569 M | 30.858 M | 44.755 M | 71.360 M | 65.846 M | 99.219 M | 129.503 M | |
| Cost of revenue | 3.256 M | 3.464 M | 5.503 M | 6.905 M | 8.830 M | 8.685 M | 11.688 M | |
| Gross profit | 46.313 M | 27.394 M | 39.252 M | 64.455 M | 57.016 M | 90.534 M | 117.815 M | |
| -40.85% | 43.29% | 64.21% | -11.54% | 58.79% | 30.13% | |||
| Operating expenses | 77.935 M | 77.471 M | 78.318 M | 72.087 M | 81.545 M | 82.008 M | 99.428 M | |
| Selling general and admin | 54.794 M | 58.173 M | 58.817 M | 57.607 M | 64.002 M | 62.404 M | 78.977 M | |
| Research and development | 23.141 M | 19.298 M | 19.501 M | 14.480 M | 17.543 M | 19.604 M | 20.451 M | |
| Total expenses | 77.935 M | 77.471 M | 78.318 M | 72.087 M | 81.545 M | 82.008 M | 99.428 M | |
| -0.60% | 1.09% | -7.96% | 13.12% | 0.57% | 21.24% | |||
| Operating income | -31.622 M | -50.077 M | -39.066 M | -7.632 M | -24.529 M | 8.526 M | 18.387 M | |
| Ebit | -27.578 M | -44.848 M | -34.884 M | -7.632 M | -21.799 M | 10.561 M | 11.969 M | |
| Pretax income | -35.058 M | -52.332 M | -41.537 M | -26.638 M | -24.781 M | 7.490 M | 17.865 M | |
| 49.27% | -20.63% | -35.87% | -6.97% | -130.22% | 138.52% | |||
| Income tax | 324.000 K | 0.000 | 0.000 | 323.000 K | 279.000 K | 80.000 K | 470.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -35.382 M | -52.332 M | -41.537 M | -10.788 M | -25.060 M | 7.410 M | 17.395 M | |
| -47.91% | 20.63% | 74.03% | -132.30% | 129.57% | 134.75% |